GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (OTCPK:CLLKF) » Definitions » 10-Year RORE %

CLLKF (BICO Group AB) 10-Year RORE % : 0.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BICO Group AB 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. BICO Group AB does not have enough data to calculate 10-Year RORE %.


BICO Group AB 10-Year RORE % Historical Data

The historical data trend for BICO Group AB's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB 10-Year RORE % Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only - - - - -

BICO Group AB Quarterly Data
Nov19 Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BICO Group AB's 10-Year RORE %

For the Medical Devices subindustry, BICO Group AB's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's 10-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where BICO Group AB's 10-Year RORE % falls into.



BICO Group AB 10-Year RORE % Calculation

BICO Group AB's 10-Year RORE % for the quarter that ended in Dec. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2024 and 10-year before.


BICO Group AB  (OTCPK:CLLKF) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


BICO Group AB 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of BICO Group AB's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB Business Description

Traded in Other Exchanges
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB Headlines

From GuruFocus

Q2 2023 BICO Group AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Preliminary Q2 2022 BICO Group AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2022 BICO Group AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2023 BICO Group AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2022 BICO Group AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2022 BICO Group AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

BICO Group AB Corporate Analyst Meeting Transcript

By GuruFocus Research 02-12-2024

BICO Group AB Corporate Call Transcript

By GuruFocus Research 02-12-2024